导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 31.97% | 123/1050 |
| 近一周 | -2.05% | 426/1104 |
| 近一月 | -6.61% | 777/1102 |
| 近一季 | -18.77% | 939/1092 |
| 近半年 | 21.83% | 123/1070 |
| 近一年 | 48.18% | 83/1018 |
| 近两年 | 172.08% | 76/926 |
| 近三年 | 115.01% | 73/834 |
| 成立以来 | 273.86% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
2.82% 268/1070 |
90.22% 72/1101 |
- - |
- - |
| 2025 | 57.64% 126/1065 |
1.56% 678/1014 |
-1.45% 811/1038 |
46.66% 112/1050 |
7.38% 81/1065 |
| 2024 | 4.08% 460/1011 |
-7.70% 683/960 |
-3.46% 544/983 |
10.72% 571/991 |
5.48% 121/1011 |
| 2023 | 26.14% 2/952 |
31.86% 10/880 |
18.16% 4/895 |
-16.74% 812/915 |
-2.77% 302/952 |
| 2022 | -25.97% 526/867 |
-21.03% 579/773 |
-1.43% 721/806 |
-11.38% 333/845 |
7.31% 131/867 |
| 2021 | 26.50% 97/740 |
-2.89% 262/580 |
16.21% 220/659 |
-4.62% 336/704 |
17.52% 10/740 |
| 2020 | 57.23% 204/554 |
10.22% 42/419 |
31.84% 100/466 |
3.73% 375/517 |
4.30% 448/554 |
| 2019 | 70.92% 38/410 |
34.72% 149/1146 |
-7.13% 863/1228 |
19.38% 17/390 |
14.44% 63/410 |
| 2018 | -33.51% 256/349 |
- - |
-18.80% 885/990 |
-5.64% 488/1000 |
-12.93% 725/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 广发电子信息传媒股票A VS. 东吴新产业精选股票A(580008) |